Physicist, 90, joins experimental trial to challenge age limits

John G Cramer to become first human recipient of bioreactor-grown mitochondria in an early-stage longevity study led by Mitrix Bio.

A new clinical effort aimed at testing mitochondrial transplantation for age reversal is drawing attention…